More vision has appeared of Aegros Founder and Managing Director, John Manusu, at the Venture & Capital Conference, held at the University of Technology Sydney in July.

John Manusu, Aegros Founder and Managing Director, being interviewed at the Venture & Capital Conference in Sydney.

After John addressed the gathering of investors in emerging health and technology investment opportunities, John paused to be interviewed by the Wholesale Investor media team. You can watch this interview on the Wholesale Investor YouTube channel.

This short interview was then shared with the conference’s online attendees and added to a virtual portal which in-person attendees could access from their devices.

Aegros always enjoys providing information on the pillars of our business plan, the opportunities inherent in the HaemaFrac®, the status of the development of our first product – a hyperimmune against Covid-19, and the important clinical trials we are involved in.

You can also watch the short presentation John delivered to investors at the Venture & Capital Conference here.

The presentation sparked some very interested investors who then learnt more about Aegros and the HaemaFrac® from the Aegros table at the conference.